Stablepharma is delighted to welcome Martin Sastre Gallardo to the R&D team at Qube Technology Park in Madrid. As Research Scientist, he will work closely with Lorena Carmona, Senior Scientist, who is leading the RNA-LNP thermostabilisation programme in Spain.
Martin joins Stablepharma after working for several years as a Senior Research Scientist at the National Centre for Biotechnology (CNB-CSIC) in Spain and has a deep knowledge of molecular and cell biology. With an MSc and MBA, he continues his studies to achieve a PhD in Molecular Biosciences at the Universidad Autónoma of Madrid, Spain.
“Martin’s experience and analytical approach will be a great addition to the team in Madrid. He has joined at an exciting time as we continue to progress our RNA-LNP vaccine thermostabilisation programme. He will also work with Lorena Carmona to identify alternative compositions, formulations and manufacturing methods, with the longer-term approach to scalability in the manufacturing process”.
Martin has extensive experience working with start-ups and research institutions within the Biotechnology Sector. “I am very excited to work with the Stablepharma team – the programmes that they are driving forward around RNA-LNP and other vaccines and biologics is something that I am very interested to see to fruition”.
Stablepharma’s technology platform, StablevaX™ converts vaccines, therapeutics and diagnostics into fridge-free products that do not require refrigeration, thereby addressing the global challenges of wastage associated with the cold chain.